beclomethasone dipropionate nasal inhaler-spray, Vancenase, Beconase (cont.)
DOSING: The usual dose for the inhalers (Beconase, Vancenase) is one inhalation in each nostril two to four times each day. Some patients may do well with lower doses, and some require higher doses. The usual dose for the nasal sprays (Beconase AQ, Vancenase AQ, Vancenase AQ DS) is one or two sprays in each nostril two to four times each day.
DRUG INTERACTIONS: No drug interactions have been described with nasal beclomethasone.
PREGNANCY: There does not appear to be any increased risk of malformations in children born to mothers exposed to beclomethasone during pregnancy. Additionally, no dependency on the drug develops, and there are no withdrawal symptoms when the medication is stopped.
NURSING MOTHERS: It is not known if beclomethasone is secreted in breast milk. Other medications in this class are secreted into breast milk. It is not known whether the small amounts that may appear in the milk are of any consequence to the infant.
SIDE EFFECTS: The most commonly noted side effects associated with nasal beclomethasone are nasal irritation (occurring in about 1 in 10 persons), sneezing (1 in 10), and, occasionally, a bloody discharge from the nose (about 1 in 50 persons).
Reference: FDA Prescribing Information
Last Editorial Review: 3/22/1999
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index
- Allergic Skin Disorders
- Bacterial Skin Diseases
- Bites and Infestations
- Diseases of Pigment
- Fungal Skin Diseases
- Medical Anatomy and Illustrations
- Noncancerous, Precancerous & Cancerous Tumors
- Oral Health Conditions
- Papules, Scales, Plaques and Eruptions
- Scalp, Hair and Nails
- Sexually Transmitted Diseases (STDs)
- Vascular, Lymphatic and Systemic Conditions
- Viral Skin Diseases
- Additional Skin Conditions